Works matching IS 00912700 AND DT 2019 AND VI 59 AND IP 5

Results: 15

Population Pharmacokinetic Analyses and Model Validation of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 763, doi. 10.1002/jcph.1370

By:

Lanke, Shankar;
Shoaf, Susan E.

Publication type:

Article

A Phase 1 Randomized Study of Single Intravenous Infusions of the Novel Nitroxyl Donor BMS‐986231 in Healthy Volunteers.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 717, doi. 10.1002/jcph.1364

By:

Cowart, Douglas;
Venuti, Robert P.;
Foo, Shi Yin;
Lynch, Kim;
Guptill, Jeffrey T.;
Noveck, Robert J.

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of Single‐Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 654, doi. 10.1002/jcph.1358

By:

Stass, Heino;
Willmann, Stefan;
Lettieri, John;
Vanevski, Konstantina M.;
James, Laura P.;
Sullivan, Janice E.;
Arrieta, Antonio C.;
Bradley, John S.

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 605, doi. 10.1002/jcph.1435
Publication type:: Article

Running Out of Time: Facilitating Off Label Approval in Cancer Treatment.

Published in:

2019

By:

Mendivil, Alberto A.;
Chad, Julie A.;
Goldstein, Bram H.

Publication type:

Letter to the Editor

4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 611, doi. 10.1002/jcph.1391

By:

Penzak, Scott R.;
Rojas‐Fernandez, Carlos

Publication type:

Article

Population Pharmacokinetics and Exposure‐Response Analyses for CPX‐351 in Patients With Hematologic Malignancies.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 748, doi. 10.1002/jcph.1366

By:

Wang, Qi;
Banerjee, Kamalika;
Gibbons, Jacqueline A.;
Vasilinin, Grygoriy;
Marier, J.F.

Publication type:

Article

Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 731, doi. 10.1002/jcph.1365

By:

Wong, Yin Cheong;
Centanni, Maddalena;
Lange, Elizabeth C. M.

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double‐Blind, Placebo‐Controlled Single‐Ascending‐Dose Study.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 688, doi. 10.1002/jcph.1361

By:

Tabuchi, Hiroko;
Katsurabara, Toshinori;
Mori, Masahiko;
Aoyama, Muneo;
Obara, Takashi;
Yasuda, Nobuyuki;
Kawano, Tetsu;
Imai, Toshio;
Ieiri, Ichiro;
Kumagai, Yuji

Publication type:

Article

Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 702, doi. 10.1002/jcph.1362

By:

Kirschbrown, Whitney P.;
Kågedal, Matts;
Wang, Bei;
Nijem, Ihsan;
Eng‐Wong, Jennifer;
Garg, Amit;
Wynne, Chris;
Wada, Russ;
Li, Hanbin;
Badovinac Crnjevic, Tanja;
Gasser, Helena;
Heeson, Sarah

Publication type:

Article

Accelerating Drug Development in Pediatric Oncology With the Clinical Pharmacology Storehouse.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 625, doi. 10.1002/jcph.1359

By:

Shebley, Mohamad;
Menon, Rajeev M.;
Gibbs, John P.;
Dave, Nimita;
Marroum, Patrick J.;
Kim, Su Y.

Publication type:

Article

Simplification of Imipenem Dosing by Removal of Weight‐Based Adjustments.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 646, doi. 10.1002/jcph.1356

By:

Lala, Mallika;
Brown, Michelle;
Kantesaria, Bhavna;
Walker, Brittany;
Paschke, Amanda;
Rizk, Matthew L.

Publication type:

Article

Population Pharmacokinetic Analysis of Decitabine in Pediatric Patients With Acute Myeloid Leukemia.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 668, doi. 10.1002/jcph.1357

By:

Zhou, Wangda;
Parasrampuria, Dolly A.;
Massarella, Joseph;
Zhang, Liping;
Nemat, Sepideh;
Nakahara, Susumu;
Poggesi, Italo;
Appiani, Carlos

Publication type:

Article

Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP‐100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 677, doi. 10.1002/jcph.1355

By:

Warita, Hitoshi;
Kato, Masaaki;
Aoki, Masashi;
Asada, Ryuta;
Yamashita, Atsuko;
Hayata, Daichika;
Adachi, Kiichi

Publication type:

Article

Accurate Prediction of Initial Busulfan Exposure Using a Test Dose With 2‐ and 6‐Hour Blood Sampling in Adult Patients Receiving a Twice‐Daily Intravenous Busulfan‐Based Conditioning Regimen.

Published in:

Journal of Clinical Pharmacology, 2019, v. 59, n. 5, p. 638, doi. 10.1002/jcph.1354

By:

Huang, Jingjing;
Li, Ziwei;
Chen, Bing;
Yang, Wanhua;
Liang, Wu;
Hu, Jiong

Publication type:

Article